Open Access<p>Efficacy and Safety of Anlotinib for Elderly Patients with Previously Treated Extensive-Stage SCLC and the Prognostic Significance of Common Adverse Reactions</p>
Author(s) -
Pengfei Song,
Ning Xu,
Qin Li
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s275624
Subject(s) - medicine , adverse effect , proportional hazards model , confidence interval , gastroenterology , stage (stratigraphy) , univariate analysis , survival analysis , diarrhea , multivariate analysis , oncology , paleontology , biology
This study was to investigate the efficacy and safety of anlotinib for elderly patients with previously treated extensive-stage small cell lung cancer (ES-SCLC) and the prognostic significance of common adverse reactions.